These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28636427)

  • 41. Current treatment for liver metastases from colorectal cancer.
    Liu LX; Zhang WH; Jiang HC
    World J Gastroenterol; 2003 Feb; 9(2):193-200. PubMed ID: 12532430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.
    Yan TD; Padang R; Morris DL
    J Am Coll Surg; 2006 Jan; 202(1):100-11. PubMed ID: 16377503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
    Bhutiani N; Akinwande O; Martin RC
    World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Continuous hepatic artery infusion chemotherapy and chemoembolization for treatment of patients with liver metastases from colorectal cancer].
    Zhao Y; Wang SM; Zhang J
    Ai Zheng; 2002 Apr; 21(4):421-3. PubMed ID: 12452025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.
    Martin RC; Edwards MJ; McMasters KM
    Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic Arterial Therapy for First-Line Treatment of Unresectable Colorectal Liver Metastases: What We Know in the Wake of Two Recent Randomized Control Trials.
    Akinwande O; Martin RC
    Cardiovasc Intervent Radiol; 2017 Feb; 40(2):315-317. PubMed ID: 27650522
    [No Abstract]   [Full Text] [Related]  

  • 47. Surgical treatment and other regional treatments for colorectal cancer liver metastases.
    Yoon SS; Tanabe KK
    Oncologist; 1999; 4(3):197-208. PubMed ID: 10394588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liver-directed therapies in colorectal cancer.
    Alsina J; Choti MA
    Semin Oncol; 2011 Aug; 38(4):561-7. PubMed ID: 21810515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Local-Regional Therapy for Oligometastatic Colorectal Cancer.
    Miller SR; Chang DT
    Cancer J; 2024 Jul-Aug 01; 30(4):272-279. PubMed ID: 39042779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver-directed therapies: does it make sense in the current therapeutic strategy for patients with confined liver colorectal metastases?
    Seront E; Van den Eynde M
    Clin Colorectal Cancer; 2012 Sep; 11(3):177-84. PubMed ID: 22306027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
    N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hepatic arterial infusion chemotherapy for colorectal liver metastases].
    Kumada T; Sone Y; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kuzuya T; Nonogaki K; Shimizu J; Yamauti T; Kawase N
    Gan To Kagaku Ryoho; 2004 May; 31(5):700-5. PubMed ID: 15170976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ablative and catheter-directed therapies for colorectal liver and lung metastases.
    Petre EN; Sofocleous CT; Solomon SB
    Hematol Oncol Clin North Am; 2015 Feb; 29(1):117-33. PubMed ID: 25475575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
    Takanishi K; Matsumoto J; Minami T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1747-51. PubMed ID: 10560386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Locoregional Liver-Directed Therapies to Treat Unresectable Colorectal Liver Metastases: A Review.
    McFadden NR; Perry LM; Ghalambor TJ; Langan RC; Gholami S
    Oncology (Williston Park); 2022 Feb; 36(2):108-114. PubMed ID: 35180338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments.
    Fiorentini G; Poddie DB; De Giorgi U; Guglielminetti D; Giovanis P; Leoni M; Latino W; Dazzi C; Cariello A; Turci D; Marangolo M
    Med Oncol; 2000 Aug; 17(3):163-73. PubMed ID: 10962525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intra-arterial infusion of 5-fluorouracil plus granulocyte-macrophage colony-stimulating factor (GM-CSF) and chemoembolization with melphalan in the treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi W; Chatzissavvidis I; Valek V
    Eur J Surg Oncol; 2001 Nov; 27(7):652-61. PubMed ID: 11669594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver-directed therapies in colorectal cancer.
    Ruan DT; Warren RS
    Semin Oncol; 2005 Feb; 32(1):85-94. PubMed ID: 15726510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current management of colorectal hepatic metastasis.
    Mayo SC; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2009 Apr; 3(2):131-44. PubMed ID: 19351284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Resection made possible following hepatic arterial infusion in 2 cases of hepatic metastases from colorectal cancer].
    Tsuji Y; Hamada H; Yasuda D; Okamura M; Watanabe K; Takahashi T; Takada J; Katsuki Y
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2100-3. PubMed ID: 12484012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.